The House Ways and Means Committee released a new analysis of drug prices in the U.S. compared to 11 other developed nations, and the results, though predictable, aren’t pretty. Here are the key findings from the report:

• The U.S. pays the most for drugs, though prices varied widely.
• U.S. drug prices were nearly four times higher than average prices compared to similar countries.
• U.S. consumers pay significantly more for drugs than other countries, even when accounting for rebates.
• The U.S. could save $49 billion annually on Medicare Part D alone by using average drug prices for comparator countries.

Read the full congressional report here.